Primary record
N-[2-[4[[[(Cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-5-methylpyrazinecarboxamide; 1-Cyclohexyl-3-[[p-[2-(5-methylpyrazinecarboxamido)
- 库存
- 6,939 克
- 纯度
- 98.9 %
- CAS
- 29094-61-9
化合物标识与属性
- CAS
- 29094-61-9
- PubChem CID
- 3478
- SMILES
- CC1=CN=C(C=N1)C(=O)NCCC2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3
- Canonical SMILES
- Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1
名称与同义词
- glipizide
- Glucotrol
- Glydiazinamide
- Glibenese
- Melizide
- Minidiab
- Minodiab
- Glucozide
- Glupizide
- Sucrazide
- Dipazide
- Glupitel
- Napizide
- Mindiab
- Ozidia
- Glibetin
- Glucolip
- Glidiab
- Minidab
- Aldiab
- Digrin
- Glican
- Glipid
- Glyde
- Glucotrol XL
- 29094-61-9
- Gluco-Rite
- Glipizida
- Glidiazinamide
- Glipizidum
- Glypidizine
- Glide
- Metaglip
- Apamid
- Semiglynase
- glipizid
- Glipizideer
- Glipizibe
- Glipizidum [INN-Latin]
- Glydiazinamide;
- Glipizida [INN-Spanish]
- Glibenese;
- Mixture Name
- Glipizideer ER
- Glucotrol (TN)
- Glipizide ER
- Glipizide XL
- Glipizide CRS
- Glipizide, solid
- Glipizide slow release
- Minodiab 5
- Glucotrol XL;
- Glipizide-d11
- glipizide/glucotrol
- Prestwick_242
- Minodiab 2.5
- Glipizide Impurity U
- C21H27N5O4S
- Glipizide (USP/INN)
- Glipizide (Standard)
- Metaglip (Salt/Mix)
- Glipizide (Glucotrol)
- X7WDT95N5C
- GLIPIZIDE [INN]
- GLIPIZIDE [JAN]
- Glipizide [USAN:BAN:INN]
- RefChem:55253
- UNII-X7WDT95N5C
- DTXSID0040676
- GLIPIZIDE [MI]
- Glipizide Kenfarma Brand
- Lopac-G-117
- MFCD00072159
- CP-28720
- GLIPIZIDE [USAN]
- K 4024
- Lacer Brand of Glipizide
- Lilly Brand of Glipizide
- Opera_ID_1908
- Prestwick0_000131
- Prestwick1_000131
- Prestwick2_000131
- Prestwick3_000131
- CHEMBL1073
- GLIPIZIDE [VANDF]
- K-4024
- CP 28720
- D0Z4SB
- GLIPIZIDE [MART.]
- Samarium(III) ionophore I
- AC1L1G0Z
- AC1Q2OG0
- GLIPIZIDE [USP-RS]
- GLIPIZIDE [WHO-DD]
- Kenfarma Brand of Glipizide
- MLS000069386
- PfizerBrand 1 of Glipizide
- CHEBI:5384
- ZJJXGWJIGJFDTL-UHFFFAOYSA-N
- Glibenese Brand of Glipizide
- TK 1320
- CBiol_001788
- Lopac0_000621
- SCHEMBL17094
- BSPBio_000202
- BSPBio_001349
- DTXCID8020676
- KBioGR_000069
- KBioSS_000069
- Pfizer Brand 2 of Glipizide
- Alphapharm Brand of Glipizide
- CP 28,720
- Glipizide [USAN:INN:BAN]
- MLS001148176
- BIDD:GT0476
- NSC-759120
- EINECS 249-427-6
- SPBio_002141
- Glipizide [USAN:USP:INN:BAN]
- Glipizide Extended-Release Tablets
- BPBio1_000224
- CP-28,720
- GTPL6821
- orb1308053
- GLIPIZIDE [ORANGE BOOK]
- GLIPIZIDE [EP MONOGRAPH]
- SCHEMBL29366401
- 4-Hydroxythieno[3,2-c]pyridine
- CTK8B3212
- HY-B0254R
- KBio2_000069
- KBio2_002637
- KBio2_005205
- KBio3_000137
- KBio3_000138
- BRN 0903495
- CID3478
- GLIPIZIDE [USP MONOGRAPH]
- MSK7193
- Bio1_000074
- Bio1_000563
- Bio1_001052
- Bio2_000069
- Bio2_000549
- GLXC-20257
- HMS1361D11
- HMS1568K04
- HMS1791D11
- HMS1989D11
- HMS2089C21
- HMS2093J09
- HMS2095K04
- HMS2233N11
- HMS3259K12
- HMS3261N04
- HMS3369L12
- HMS3402D11
- HMS3655G04
- HMS3712K04
- HMS5079J16
- Pharmakon1600-01505433
- ZINC537795
- K4024
- METAGLIP COMPONENT GLIPIZIDE
- MSK7193-100AM
- N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-5-methylpyrazine-2-carboxamide
- BCP09195
- CID:3478
- Glucotrol XL, Glucotrol, Glipizide
- HY-B0254
- KS-1068
- PXB42607
- MSK7193-1000AM
- Tox21_110156
- Tox21_301834
- Tox21_500621
- ANW-41980
- BBL028143
- BDBM50012956
- C21-H27-N5-O4-S
- EBC-06101
- NCGC00015462-07
- NSC759120
- NSC813218
- s1715
- STK631952
- ZINC00537795
- CP 28720;K 4024
- SMR000058455
- AKOS005564405
- Tox21_110156_1
- ACN-048274
- CCG-204710
- CS-2239
- DB01067
- FG01273
- LP00621
- NC00564
- NSC 759120
- NSC-813218
- SDCCGSBI-0050603.P003
- TK-1320
- CAS-29094-61-9
- IDI1_033819
- G-117
- Glipizide 100 microg/mL in Acetonitrile
- NCGC00015462-01
- NCGC00015462-02
- NCGC00015462-03
- NCGC00015462-04
- NCGC00015462-05
- NCGC00015462-06
- NCGC00015462-08
- NCGC00015462-09
- NCGC00015462-10
- NCGC00015462-11
- NCGC00015462-12
- NCGC00015462-14
- NCGC00015462-23
- NCGC00016802-01
- NCGC00023748-03
- NCGC00023748-04
- NCGC00023748-05
- NCGC00023748-06
- NCGC00023748-07
- NCGC00255522-01
- NCGC00261306-01
- AC-15789
- AN-15826
- BC209538
- CPD000058455
- J20.336J
- N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methylpyrazine-2-carboxamide
- SAM002564210
- SC-13933
- SID:53787230
- SY009252
- 1-Cyclohexyl-3-((p-(2-(5-methylpyrazinecarboxamido)ethyl)phenyl)sulfonyl)urea
- SBI-0050603.P002
- AB0012143
- LS-159679
- TC-063559
- TL8006447
- A8438
- EU-0100621
- FT-0626714
- FT-0659737
- G0369
- NS00009815
- ST50826363
- SW196549-3
- D00335
- Pyrazinecarboxamide, N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-5-methyl-
- 094G619
- A819760
- D005913
- N-(4-(beta-(5-Methylpyrazine-2-carboxamido)ethyl)benzenesulphonyl)-N'-cyclohexylurea
- N-[2-(4-{[(cyclohexylcarbamoyl)amino]sulfonyl}phenyl)ethyl]-5-methylpyrazine-2-carboxamide
- SR-01000000010
- 1-cyclohexyl-3-[[p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl]sulfonyl]urea
- 29094-66-4
- I06-0186
- I06-1985
- Q3108899
- SR-01000000010-2
- SR-01000000010-5
- Urea, 1-cyclohexyl-3-((p-(2-(5-methylpyrazinecarboxamido)ethyl)phenyl)sulfonyl)-
- BRD-K12219985-001-04-8
- BRD-K12219985-001-15-4
- BRD-K12219985-001-25-3
- BRD-K12219985-001-26-1
- Glipizide Solution in Acetonitrile/Methanol, 100ug/mL
- N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-5-methylpyrazine-2-carboxamide
- 1-Cyclohexyl-3-{4-[2-(5-methylpyrazine-2-carboxamido)ethyl]phenylsulfonyl}urea
- Glipizide Solution in Acetonitrile/Methanol, 1000ug/mL
- N-[4-(3-Cyclohexylureidosulfonyl)phenethyl]-5-methyl-2-pyrazinecarboxamide
- Z1575081877
- B2692-089502
- Glipizide, European Pharmacopoeia (EP) Reference Standard
- N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-5-methyl-pyrazine-2-carboxamide
- 1-cyclohexyl-3-({p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl}sulfonyl)urea
- Glipizide, United States Pharmacopeia (USP) Reference Standard
- N-{4-[beta-(5-methylpyrazine-2-carboxamido)ethyl]benzenesulphonyl}-N'-cyclohexylurea
- 2-Pyrazinecarboxamide, N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-5-methyl-
- Glipizide, Pharmaceutical Secondary Standard; Certified Reference Material
- Pyrazinecarboxamide, N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-5-methyl-
- 1-cyclohexyl-3-(4-(2-(2-methylpyrazine-5-carboxamido)ethyl)phenylsulfonyl)urea
- 1-Cyclohexyl-3-{{p=[2-[5-methylpyrazine-carboxamido)-ethyl]phenyl}sulphonyl}urea
- N-(2-(4-(((cyclohexylcarbamoyl)amino)sulfonyl)phenyl)ethyl)-5-methylpyrazine-2-carboxamide
- N-(4-(.beta.-(5-Methylpyrazine-2-carboxamido)ethyl)benzenesulphonyl)-N'-cyclohexylurea
- N-[4-[N-(Cyclohexylcarbamoyl)sulfamoyl]phenethyl]-5-methylpyrazine-2-carboxamide
- Urea, 1-cyclohexyl-3-[[p-[2-(5-methylpyrazinecarboxamido)ethyl]phenyl]sulfonyl]-
- 1189426-07-0
- 172964-66-8
- 2-Pirazincarboxamida, N-[2-[4-[[[( ciclohexilamino) carbonil] amino] sulfonil] fenil] etil]-5-metil-
- 249-427-6
- N-(2-[4-(([(Cyclohexylamino)carbonyl]amino)sulfonyl)phenyl]ethyl)-5-methyl-2-pyrazinecarboxamide
- N-[2-(4-{[(cyclohexylamino)carbonylamino]sulfonyl}phenyl)ethyl](5-methylpyrazi n-2-yl)carboxamide
- N-[2-[4-[[[(Cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-5-methyl-2-pyrazinecarboxamide
- n-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-5-methylpyrazinecarboxamide
- N-[2-[4[[[(Cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-5-methylpyrazinecarboxamide; 1-Cyclohexyl-3-[[p-[2-(5-methylpyrazinecarboxamido)